US Patent Issued for Atlantic Healthcare’s Alicaforsen to Treat IBD Pouchitis
News
A U.S. patent has been issued to Atlantic Healthcare’s investigational drug alicaforsen for the treatment of inflammatory bowel disease (IBD). The patent (No. 9453221) extends the use of alicaforsen in IBD-related rectal stump inflammation and ... Read more